FTSV - Forty Seven, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - FTSV (1667633)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
42 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-06-20
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$11.04-8,30160,719-12%-$91,626
D
2019-05-20
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$12.10-16,50060,719-21%-$199,726
M
2019-05-15
FTSVMajeti RavindraDirS - Sale$16.02-4,3111,421,4000%-$69,044
D
2019-05-03
FTSVTakimoto Chris HChief Medical OfficerS - Sale+OE$17.99-8,0000-100%-$143,951
2019-04-26
FTSVWeissman IrvingDirS - Sale$18.35-20,0002,052,761-1%-$366,978
D
2019-04-18
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$18.12-16,50060,719-21%-$299,054
2019-04-15
FTSVMajeti RavindraDirS - Sale$18.30-25,0001,425,711-2%-$457,505
D
2019-04-04
FTSVTakimoto Chris HChief Medical OfficerS - Sale+OE$16.39-8,0000-100%-$131,105
M
2019-04-03
FTSVWeissman IrvingDirS - Sale$17.11-9,9002,072,7610%-$169,432
2019-03-29
FTSVWeissman IrvingDirS - Sale$18.00-1002,082,6610%-$1,800
2019-03-26
FTSVWeissman IrvingDirS - Sale$15.98-10,0002,082,7610%-$159,812
D
2019-03-19
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$18.15-16,50060,719-21%-$299,401
M
2019-03-15
FTSVMajeti RavindraDirS - Sale$17.83-35,0001,450,711-2%-$623,953
D
2019-03-04
FTSVTakimoto Chris HChief Medical OfficerS - Sale+OE$16.94-8,0000-100%-$135,550
2019-03-01
FTSVWeissman IrvingDirS - Sale$17.04-3,6162,092,7610%-$61,603
M
2019-02-25
FTSVWeissman IrvingDirS - Sale$16.98-26,3842,096,377-1%-$448,103
DM
2019-02-19
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$14.99-16,50060,719-21%-$247,343
2019-02-19
FTSVTakimoto Chris HChief Medical OfficerS - Sale$15.05-2,5000-100%-$37,621
D
2019-02-04
FTSVTakimoto Chris HChief Medical OfficerS - Sale+OE$14.86-8,0000-100%-$118,874
M
2019-02-01
FTSVWeissman IrvingDirS - Sale$15.02-9,6642,122,7610%-$145,167
M
2019-01-30
FTSVMajeti RavindraDirS - Sale$14.48-20,0001,518,348-1%-$289,554
2019-01-28
FTSVWeissman IrvingDirS - Sale$15.00-3362,132,4250%-$5,041
D
2019-01-18
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$14.59-20,0009,032-69%-$291,892
M
2019-01-15
FTSVMajeti RavindraDirS - Sale$15.77-27,3631,538,348-2%-$431,631
2019-01-09
FTSVWeissman IrvingDirS - Sale$17.05-10,0002,132,7610%-$170,490
2018-12-26
FTSVWeissman IrvingDirS - Sale$15.77-10,0002,142,7610%-$157,685
D
2019-01-04
FTSVTakimoto Chris HChief Medical OfficerS - Sale+OE$15.55-8,0000-100%-$124,362
D
2018-12-26
FTSVMcCamish Mark AnthonyPres, CEOS - Sale+OE$15.90-12,0009,032-57%-$190,806
M
2018-08-22
FTSVMhatre Ravi10%P - Purchase$15.08+166,8584,492,531+4%+$2,515,424
M
2018-08-16
FTSVNieh Peter10%P - Purchase$15.18+67,5004,393,173+2%+$1,024,893
2018-08-16
FTSVSchaepe Christopher JDir, 10%P - Purchase$15.03+66,5424,392,215+2%+$1,000,013
D
2018-07-02
FTSVWhite James N10%P - Purchase$16.00+142,1503,066,309+5%+$2,274,400
D
2018-07-02
FTSVSutter Hill VenturesFormer 10% HolderP - Purchase$16.00+134,7352,906,372+5%+$2,155,760
D
2018-07-02
FTSVSpeiser Michael L10%P - Purchase$16.00+140,4803,030,299+5%+$2,247,680
D
2018-07-02
FTSVPullara Samuel J IIIFormer 10% HolderP - Purchase$16.00+136,7942,950,781+5%+$2,188,704
D
2018-07-02
FTSVDyckerhoff Stefan AFormer 10% HolderP - Purchase$16.00+136,6502,947,677+5%+$2,186,400
D
2018-07-02
FTSVCoxe Tench10%P - Purchase$16.00+153,0493,301,419+5%+$2,448,784
D
2018-07-02
FTSVBird Jeffrey WDir, 10%P - Purchase$16.00+138,9873,126,666+5%+$2,223,792
D
2018-07-02
FTSVLightspeed Venture Partners Select Ii, L.P.10%P - Purchase$16.00+468,7501,784,269+36%+$7,500,000
D
2018-07-02
FTSVSchaepe Christopher JDir, 10%P - Purchase$16.00+468,7501,784,269+36%+$7,500,000
D
2018-07-02
FTSVClarus Lifesciences Iii, L.P.10%P - Purchase$16.00+200,0004,755,440+4%+$3,200,000
D
2018-07-02
FTSVHenner DennisDir, 10%P - Purchase$16.00+200,0003,816,951+6%+$3,200,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top